These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 100468)

  • 1. Pathogenesis of experimental Pseudomonas keratitis in the guinea pig: bacteriologic, clinical, and microscopic observations.
    Van Horn DL; Davis SD; Hyndiuk RA; Alpren TV
    Invest Ophthalmol Vis Sci; 1978 Nov; 17(11):1076-86. PubMed ID: 100468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental Pseudomonas keratitis in the rabbit: bacteriologic, clinical, and microscopic observations.
    Van Horn DL; Davis SD; Hyndiuk RA; Pederson HJ
    Invest Ophthalmol Vis Sci; 1981 Feb; 20(2):213-21. PubMed ID: 6780486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The immune system in experimental Pseudomonas keratitis. Model and early effects.
    Twining SS; Lohr KM; Moulder JE
    Invest Ophthalmol Vis Sci; 1986 Apr; 27(4):507-15. PubMed ID: 3082789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histologic study of corneal lesions caused by the slime-GLP glycolipoprotein of Pseudomonas aeruginosa].
    Pharmakakis N; Papadakis E; Gartaganis S; Bechrakis M; Dimitracopoulos G; Varakis I
    Ophtalmologie; 1990; 4(1):72-5. PubMed ID: 2123533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of vitamin A deficiency on the early response to experimental Pseudomonas keratitis.
    Twining SS; Zhou X; Schulte DP; Wilson PM; Fish B; Moulder J
    Invest Ophthalmol Vis Sci; 1996 Mar; 37(4):511-22. PubMed ID: 8595951
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Experimental Pseudomonas aeruginosa ulcerative keratitis model in the dog.
    Wyman M; Swanson C; Kowalski JJ; Powers JD; Boraski EA
    Am J Vet Res; 1983 Jun; 44(6):1135-40. PubMed ID: 6870021
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bacteriologic cure of experimental Pseudomonas keratitis.
    Davis SD; Sarff LD; Hyndiuk RA
    Invest Ophthalmol Vis Sci; 1978 Sep; 17(9):916-8. PubMed ID: 100471
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Keratotomy model of pseudomonas keratitis: gentamicin chemotherapy.
    Brockman EB; Tarantino PA; Hobden JA; Hill JM; O'Callaghan RJ; Kaufman HE; Insler MS
    Refract Corneal Surg; 1992; 8(1):39-43. PubMed ID: 1554638
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of the mouse keratitis produced with Pseudomonas aeruginosa.
    Kawaharajo K; Homma JY
    Jpn J Exp Med; 1975 Dec; 45(6):515-24. PubMed ID: 822189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylactic and therapeutic efficacy of immunoglobulin G antibodies to Pseudomonas aeruginosa lipopolysaccharide against murine experimental corneal infection.
    Preston MJ; Gerçeker AA; Koles NL; Pollack M; Pier GB
    Invest Ophthalmol Vis Sci; 1997 Jun; 38(7):1418-25. PubMed ID: 9191605
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Purification of Pseudomonas aeruginosa proteases and microscopic characterization of pseudomonal protease-induced rabbit corneal damage.
    Kreger AS; Gray LD
    Infect Immun; 1978 Feb; 19(2):630-48. PubMed ID: 415981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
    Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
    Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different strains of Pseudomonas aeruginosa isolated from ocular infections or inflammation display distinct corneal pathologies in an animal model.
    Cole N; Willcox MD; Fleiszig SM; Stapleton F; Bao B; Tout S; Husband A
    Curr Eye Res; 1998 Jul; 17(7):730-5. PubMed ID: 9678419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adherence of Pseudomonas aeruginosa to the injured cornea: a step in the pathogenesis of corneal infections.
    Ramphal R; McNiece MT; Polack FM
    Ann Ophthalmol; 1981 Apr; 13(4):421-5. PubMed ID: 6787968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of innate and adaptive immunity in the pathogenesis of keratitis.
    Hazlett LD
    Ocul Immunol Inflamm; 2005; 13(2-3):133-8. PubMed ID: 16019672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of Pseudomonas aeruginosa elastase in corneal ring abscess formation in pseudomonal keratitis.
    Ijiri Y; Yamamoto T; Kamata R; Aoki H; Matsumoto K; Okamura R; Kambara T
    Graefes Arch Clin Exp Ophthalmol; 1993 Sep; 231(9):521-8. PubMed ID: 8224956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corneal virulence of Pseudomonas aeruginosa elastase B and alkaline protease produced by Pseudomonas putida.
    Thibodeaux BA; Caballero AR; Marquart ME; Tommassen J; O'Callaghan RJ
    Curr Eye Res; 2007 Apr; 32(4):373-86. PubMed ID: 17453960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The establishment of a rat model of chronic pulmonary infection due to Pseudomonas aeruginosa].
    Wang WF; Fang XQ; Liu YN
    Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):46-50. PubMed ID: 18346380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased severity of Pseudomonas aeruginosa corneal infection in strains of mice designated as Th1 versus Th2 responsive.
    Hazlett LD; McClellan S; Kwon B; Barrett R
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):805-10. PubMed ID: 10711697
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of experimental diffuse lamellar keratitis using a novel platelet-activating factor receptor antagonist.
    Esquenazi S; He J; Bazan HE; Bazan NG
    J Cataract Refract Surg; 2004 Apr; 30(4):884-91. PubMed ID: 15093656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.